10-K: FMC Corp Navigates Inventory Destocking, Launches Restructuring Plan Amidst Market Downturn

FMC Corporation's 2023 results were significantly impacted by industry-wide inventory destocking, leading to a global restructuring plan to optimize costs and improve productivity.

Summary

• FMC Corporation's 2023 revenue declined by approximately 23% due to inventory destocking across all regions.
• The company initiated a global restructuring plan, 'Project Focus', to right-size its cost base and optimize its organizational structure.
• Despite market challenges, sales of newer and more differentiated products, including diamides, outperformed the overall portfolio.
• Approximately $590 million in 2023 sales came from products launched in the last five years, representing 14% of the total revenue.
• The company expects 2024 revenue to be in the range of $4.50 billion to $4.70 billion, an increase of approximately 2.5 percent at the midpoint versus 2023.
• Adjusted EBITDA for 2024 is expected to be between $900 million and $1.05 billion.
• Adjusted earnings per share for 2024 are projected to be in the range of $3.23 to $4.41.
• The company's diamides, Rynaxypyr and Cyazypyr active ingredients, represented approximately $1.8 billion in combined sales and approximately 39 percent of the total revenue in 2023.
• FMC is committed to a 42% reduction in Scopes 1 and 2, and 25% reduction in Scope 3 by 2030, with a net-zero target across the value chain by 2035.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While the company faces challenges like declining revenue and inventory destocking, it is taking proactive measures through restructuring and focusing on innovative products. The outlook for 2024 suggests a potential recovery, but uncertainties remain.

Positives

• Sales of newer and more differentiated products, including diamides, outperformed the overall portfolio.
• The company successfully launched Premio Star insecticide in Brazil.
• FMC is committed to sustainability goals, including net-zero greenhouse gas emissions across the value chain by 2035.
• FMC earned a top score in the Human Rights Campaign Foundations Corporate Equality Index for LGBTQ+ workplace equality.
• FMC's Total Recordable Incident Rate of 0.0547 continues to be among the lowest in the industry globally.

Negatives

• FMC experienced a significant decline in revenue due to inventory destocking, with a year-over-year decrease of approximately 23%.
• The company incurred $75.2 million in currency-related charges, primarily driven by actions taken by the Argentine Government.
• Interest expense increased by $85.4 million due to higher interest rates.
• The composition of matter patent that covers cyantraniliprole (also known as Cyazypyr active) expired in a number of countries starting in January 2024.

Risks

• The company faces risks related to competition, climate conditions, and changing regulatory environments.
• Fluctuations in commodity prices and supply chain disruptions could negatively impact operating results.
• Litigation and environmental risks could lead to substantial liabilities.
• The company's innovation efforts are protected by patents, trade secrets and other intellectual property rights that cover many of our current products, manufacturing processes, and product uses, as well as many aspects of our research and development activities supporting our new product pipeline.
• Economic and geopolitical changes, including trade restrictions and political instability, could adversely affect the business.
• Information technology security and data privacy risks pose a threat to business operations and sensitive information.

Future Outlook

FMC expects 2024 revenue to be in the range of approximately $4.50 billion to $4.70 billion, up approximately 2.5 percent at the midpoint versus 2023. Adjusted EBITDA is expected to be between $900 million and $1.05 billion, and adjusted earnings per share are projected to be in the range of $3.23 to $4.41.

Management Comments

• FMC is committed to delivering products that improve agricultural productivity protecting the environment for future generations.
• FMC is aligned with the UN Sustainable Development Goals #2 (Zero Hunger), #8 (Decent Work and Economic Growth), #13 (Climate Action) and #15 (Life on Land).

Industry Context

The agrochemicals industry is consolidated with five innovation companies representing approximately 73 percent of global sales, including FMC, ChemChina (owner of Syngenta Group), Bayer AG, BASF AG and Corteva Agriscience.

Comparison to Industry Standards

• FMC competes with major players like Syngenta, Bayer, BASF, and Corteva Agriscience, which together control a significant portion of the global crop protection market.
• FMC employs differentiated strategies and competes with unique technologies focusing on certain crops, markets and geographies, while also being supported by a low-cost manufacturing model.
• FMC's Total Recordable Incident Rate of 0.0547 continues to be among the lowest in the industry globally and in the top decile of peer companies in North America, placing our company among the safest organizations in the chemical industry.

Corporate Governance

Legal Proceedings

• FMC is involved in securities litigation related to alleged misrepresentations regarding business, operations, and prospects.
• The company is also involved in asbestos-related personal injury litigation.
• FMC has been named in approximately 500 cases pending in the Philadelphia Court of Common Pleas Mass Tort Program; these cases are in a preliminary pleading phase under review by the presiding judge. In general, plaintiffs allege they were exposed to paraquat, and as a result of this exposure, they developed disease or other health conditions.

Stakeholder Impact

• Shareholders may experience short-term volatility due to the restructuring and market challenges.
• Employees may be affected by workforce reductions as part of Project Focus.
• Customers may benefit from the company's focus on innovative and sustainable solutions.
• Suppliers may be impacted by changes in sourcing strategies and contract terms.

Next Steps

• The company will continue to implement Project Focus to achieve cost savings and improve productivity.
• FMC will focus on growing sales of new products and differentiated technologies.
• The company will continue to monitor and manage its supply chain and raw material costs.
• FMC will continue to follow legislative and regulatory developments regarding climate change, including climate-related financial disclosures and green taxes.

Key Dates

Keywords

FMC Corporation, agrochemicals, crop protection, inventory destocking, restructuring, diamides, sustainability, financial results, patent expiration, Rynaxypyr, Cyazypyr, Project Focus